The US Food and Drug Administration (FDA) has granted 510(k) clearance to Getinge’s new software options for the Servo-u and Servo-n ventilators as well as the novel Servo-u MR ventilator for the MRI room.

Getinge North America president Eric Honroth said: “The Covid-19 pandemic and the heightened awareness of respiratory health have driven the need for personalised ventilation solutions for critically ill patients.

“Now more than ever, options for personalised lung protection and personalised weaning solutions are at the forefront of respiratory patient health.”

The software upgrade for the Servo-u and Servo-n adds various new functionalities and options across adult, paediatric and neonatal patient categories.

The latest development expands the company’s portfolio of lung-protective tools, which includes a standardised and automated workflow for directing lung recruitment called Automatic Stepwise Recruitment Manoeuvre (Auto SRM). This aids clinicians in detecting a customised positive end-expiratory pressure (PEEP) that offers the lowest driving pressure, which is linked to patient survival in acute respiratory distress syndrome (ARDS) cases.

The lung-protective toolkit has a stress index and transpulmonary pressure monitoring, including crucial parameters for evaluating lung stress during controlled and spontaneous ventilation. This could aid in dividing the cognitive workload optimally between the clinician and the ventilator.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Furthermore, the clearance includes Heliox therapy, which combines helium and oxygen to help laminar flow and reduce airway pressure through its low density. The company claims this aids in lowering the work of breathing (WoB) in patients with obstructive lung diseases.

The company has also received clearance to launch the Servo-u MR in the US market, which will complement the Servo family and expand its platform of ventilators into the MRI room.

The Servo-u MR has a magnetic field indicator with visual and audible alerts as well as an auto-lock handle that locks all four wheels on releasing the ventilator.

Getinge noted that the novel options and the Servo-u MR ventilator are anticipated to be available in the US in July.